SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-07-000020
Filing Date
2007-03-12
Accepted
2007-03-12 16:35:55
Documents
2
Period of Report
2007-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 EARNINGS YEAR ENDED 2006 earningsyearend2006.htm 8-K 22755
2 PRESS RELEASE EARNINGS 2006 earningspressrelease2006.htm EX-99.1 23694
  Complete submission text file 0000812796-07-000020.txt   48177
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 07687991
SIC: 2834 Pharmaceutical Preparations